Aviva Plc
Source: SEC Form 13F · as of Mar 2026Aviva Plc holds 16 biotech & pharma companies tracked by BioSniper, totaling $351.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$351.1M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 1,174,576 | $163.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 91,176 | $70.4M |
| TEVATeva Pharmaceutical Industries Limited | 1,300,604 | $39.2M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 114,003 | $37.7M |
| INSMINSMED Inc | 122,074 | $20.0M |
| INCYIncyte Corp. | 148,088 | $13.9M |
| RVMDREVOLUTION MEDICINES, INC. | 21,460 | $2.1M |
| EXELEXELIXIS, INC. | 25,153 | $1.1M |
| PTCTPTC THERAPEUTICS, INC. | 6,764 | $461K |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 7,294 | $457K |
| ACADACADIA PHARMACEUTICALS INC | 20,302 | $452K |
| HRMYHarmony Biosciences Holdings, Inc. | 14,997 | $420K |
| KROSKeros Therapeutics, Inc. | 34,307 | $379K |
| INVAInnoviva, Inc. | 13,298 | $310K |
| STOKStoke Therapeutics, Inc. | 9,272 | $302K |
| ADMAADMA BIOLOGICS, INC. | 28,686 | $258K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.